1.11  -0.18 (-13.95%)		06-25 16:00
Open: 1.3 High: 1.3356 Volume: 103,490		Pre. Close: 1.29 Low: 1.095 Market Cap: 6(M)

Short term
Mid term
Targets	6-month :	1.9	1-year :	2.28
Resists	First :	1.62	Second :	1.95
Pivot price	1.37
Supports	First :	1.09	Second :	0.91
MAs	MA(5) :	1.31	MA(20) :	1.44
	MA(100) :	1.62	MA(250) :	1.5
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	6.3	D(3) :	14.8
RSI	RSI(14): 31
52-week	High :	3.92	Low :	0.59

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MBAI ] has closed below the lower bollinger band by 25.0%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 41.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.34 - 1.35	1.35 - 1.35
Low:	1.07 - 1.09	1.09 - 1.09
Close:	1.1 - 1.11	1.11 - 1.12

Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.

Wed, 24 Jun 2026
MBody AI–Check-Cap (NASDAQ: MBAI) reverse recap shows 2025 pro forma profit - Stock Titan

Mon, 02 Feb 2026
Check-Cap advances toward MBody AI merger completion - Investing.com

Wed, 28 Jan 2026
The Most Unfair Trading Advantage You’ve Never Heard Of - StocksToTrade

Tue, 27 Jan 2026
Check-Cap (MBAI) Stock Price, News & Analysis - MarketBeat

Mon, 26 Jan 2026
Penny stock Check-Cap has nearly doubled its value today – what’s going on with MBody AI merger? - MSN

Mon, 26 Jan 2026
Penny Stock Check-Cap Has Nearly Doubled Its Value Today – What’s Going On With MBody AI Merger? - Stocktwits

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	8 (M)
Shares Float	6 (M)
Held by Insiders	20.8 (%)
Held by Institutions	0.4 (%)
Shares Short	66 (K)
Shares Short P.Month	140 (K)

EPS	0.66
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.49
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-37.8 %
Return on Equity (ttm)	416.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.29
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	1.68
PEG Ratio	0
Price to Book value	2.26
Price to Sales	0
Price to Cash Flow	-186.53

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.